Summary A twelve year series of 375 patients with gastric carcinoma has been studied. Patients were divided into TNM Groups. Tumours were classified as intestinal-type and diffuse. The patients with TI -3NOMO diffuse tumour were ten years younger than the patients with TI -3NOMO intestinal-type tumour. The mean age increased from Ti through T2 to those with T3 tumour. The age differences between the T-stages were the same in both groups, which indicate that once started, the diffuse and the intestinal-type tumours infiltrate the gastric wall at about the same rate. Among the patients with intestinal-type tumour, those with lymph node or distant metastases were three to seven years younger than the patients without metastases. On the other hand, the patients with diffuse tumour and metastases were as many years older than the patients without metastases. Apparently, tumour spread is age dependent and different between the two types of gastric carcinoma. The ill repute of the diffuse gastric carcinoma may therefore be explained by the advanced stage of that tumour at the time of treatment as compared to the intestinal-type tumour. The diffuse tumour seems to be clinically more silent and to give symptoms at a later stage than the intestinal-type tumour.
Twenty-five years ago Pekka Lauren published his paper on the classification of gastric carcinoma into two main histopathological types, the intestinal-type and the diffuse (Lauren, 1965 ). Lauren's classification is now widely accepted and numerous reports have described significant differences between the two types of gastric carcinoma.
The discrimination between the two types of tumour is particularly important for the clinical management of patients with gastric carcinoma. The diffuse carcinoma tends to be more wide-spread at the time of treatment. Accordingly, it is recommended that resections should be more extensive in patients with this tumour than in patients with the intestinaltype tumour (Gall & Hermanek 1985 , Heberer et al., 1988 . It is well documented that the prognosis for the diffuse carcinoma is poorer than for the intestinal-type carcinoma (Lauren, 1965; Stemmermann & Brown, 1974; Ribeiro et al., 1981; Hermanek, 1986; Viste et al., 1986) .
It has also been reported that patients with diffuse gastric carcinoma are younger than those with the intestinal-type (Lauren, 1965; Noda et al., 1980; Ribeiro et al., 1981; Hanai et al., 1982; Mecklin et al., 1988) . Two studies are concordant that this difference is in the order of 7-8 years (Lauren, 1965; Ribeiro et al., 1981) .
It has now become clear that age in itself is a prognosticator of some cancers (Ershler, 1986) . Observations of cancers of the lung, breast, colon, prostate gland and kidney have shown that once a tumour has developed, growth and spread are slower in the elderly (Ershler, 1986) . In line with these observations, it has also been shown that advancing age reduces growth of some experimental tumours. On the other hand, there are also experimental tumours where the growth is enhanced with increasing age (Yuhas et al., 1974; Rockwell, 1981; Ershler et al., 1984; Ershler, 1986) (Janssen et al., 1991) .
The primary tumours were classified as intestinal-type in 217 patients and diffuse in 97 patients, whereas the tumours from 61 patients were unclassifiable. All classifications were done by one of us (HMM).
The patients were divided in TNM groups as advised by the International Union against Cancer (Hermanek & Sobin, 1987) . Tumour in lymph nodes was, however, denoted N+ irrespective of site. The T-and N-classifications were as a rule based on the pathologist's findings in the resected specimens. In cases of exploratory laparotomy with no gastric resection, the T-classification stems from the findings during surgery. Distant metastases were verified histologically in most cases. Less than 10% of the patients were not operated, mainly because of wide spread metastases. In this group of patients the primary tumours were denoted TX (X; i.e. not sufficient information for classification.)
The age difference between men and women and between patients with intestinal-type and diffuse carcinoma was tested by one-way analysis of variance. The age difference between patients with intestinal-type and diffuse tumour in the various TNM groups was tested by two-way analysis of variance with unequal cell-sizes, as discussed by Overall and Spiegel (1969) . The analysis was run by the program 4V in BMDP (Dixon, 1983; Davidson & Toporek, 1983) .
Results
The number of patients with intestinal-type and diffuse tumour in each defined group of disease extent is seen in Figure 1 . The ratio of diffuse tumour increased both with increasing T and with increasing extragastric spread. In the TlNOMO group the ratio was 0.10 as opposed to 0.58 in the T4NxM1 group. Among the TxNxM1 patients, 16 had the intestinal-type tumour and seven the diffuse tumour.
In the whole series there was no age difference between men and women (P = 0.72), the mean ages ( ± 1 s.e.m.) were 67.4 ± 0.6 and 67.2 ± 1.1 years respectively. The mean age of the patients with intestinal-type tumour was 3.8 years higher than that of the patients with diffuse tumour (68.7 ± 0.7 and 64.9 ± 1.2 years respectively, P = 0.0075). Among the patients with intestinal-type tumour, the age difference from the TINOMO to the T3NOMO group was 8.9 years. The patients with T2 and T3 tumours and lymph node or distant metastases were younger than the patients without metastases; the difference within one T group was at the most 7.5 years (T3NOMO vs T3NxMl).
The patients with T2NOMO diffuse tumour were 9.7 years younger than those with intestinal-type tumour. For the patients with T3NOMO tumour this difference was 9.6 years. (The TINOMO patients with diffuse tumour were 11.0 years younger than the patients with TINOMO intestinal-type tumour, but here the number of patients with diffuse tumour was 2). The patients with diffuse tumour and metastases were older than those without, the greatest difference within one T group 6.5 years (T3NOMO vs T3NxMl).
The age difference of patients with or without metastases was significantly different between those with diffuse and intestinal-type tumour, P = 0.03. There was no clear age difference between the patients with diffuse and intestinaltype tumour and metastases, except for those with T4NxM1 tumour. In this particular group patients with diffuse tumour were younger than the patients with intestinal-type tumour, mean ages were respectively 61.3 and 68.7 years. This difference was, however, insignificant (P>0.05).
Discussion
The diffuse gastric carcinoma was as a rule more advanced at the time of treatment than the intestinal-type carcinoma. This finding accords with previous reports in that the diffuse tumour penetrates deeper into the gastric wall and more often has lymph node metastases than the intestinal-type tumour (Inberg et al., 1965; Noda et al., 1980; Ribeiro et al., 1981; Gall & Hermanek, 1985 , Hermanek, 1986 . Additionally, we also found that the highest ratio of diffuse tumours was among the patients with distant metastases. This observation has not been so clear in other studies, which have dealt mainly with patients undergoing potentially curative surgery.
We suppose that the deep infiltration of the diffuse primary tumour and the high frequency of lymph node metas- tases may have prompted the idea that the diffuse gastric carcinoma grows and spreads at a faster rate than the intestinal-type carcinoma (Inberg et al., 1965; Noda et al., 1980) . Among our patients with no extragastric spread of tumour (NOMO), there was an increment with age from Ti to T2 and further to those with T3 tumour. These age differences were nearly the same in patients with the diffuse and with the intestinal-type tumour; from the TI to the T3 patients the differences were 10.4 and 8.9 years respectively. In our opinion, this observation indicates that once started, the two types of tumour penetrate into the gastric wall at about the same rate.
In the different T-stages of the NOMO tumours, the patients with the diffuse type were approximately 10 years younger than those with the intestinal-type tumour. In the whole series, however, the age difference between the two types was 3.8 years. Other reports say that the patients with 751 diffuse gastric carcinoma are 7-8 years younger than the patients with intestinal-type carcinoma (Lauren, 1965 , Ribeiro et al., 1981 . We suppose that the variations in age differences between the two groups of patients in various studies may be explained by different TNM distributions. Clearly, the 10 years difference between the T-stages in the NOMO patients cannot be taken as evidence that the diffuse tumour starts 10 years earlier than the other. A rather surprising finding was that the patients with intestinal-type carcinoma and lymph node or distant metastases were between 3 and 7 years younger than the NOMO patients in each T-stage. On the other hand, the patients with diffuse tumour and metastases were as many years older than those without metastases.
Accordingly, the younger the patient with intestinal-type gastric carcinoma, the more readily it sets up metastases, whereas the younger the patient with diffuse gastric carcinoma, the more it is confined to the stomach. The spread of tumour is obviously age dependent, and this dependency is different between the two types of carcinoma.
These findings may be explained by some modern theories of cancer biology, particularly those presented by Ershler (1986) and Prehn and Prehn (1989) . It is well documented that some tumours grow more rapidly in young people than in older people. Apparently, the competent immunity of the young often enhances rather than retards tumour growth. This may be due to the immunofacilitating mechanisms of the young (Ershler, 1986) , affecting various tumours differently. Applied to gastric carcinoma, the immunofacilitating mechanisms seem to be confined to the intestinal-type tumour. For the diffuse tumour, on the other hand, the competent immunity of the young evidently restrains cancer spread. Our findings are in line with those of Noda et al. (1980) , emphasising the fair prognosis of the early stage diffuse gastric carcinoma as opposed to the intestinal-type carcinoma.
The ill repute of the diffuse gastric carcinoma must therefore be sought elsewhere than in the young age of the patient or the growth rate of that tumour. Our finding that the ratio of diffuse tumours increased with increasing T-stage strongly indicates that the diffuse gastric carcinoma is clinically silent for a longer time than the intestinal-type. This may be due to the different growth pattern of the two types of carcinoma (Inberg et al., 1965 , Noda et al., 1980 Gall & Hermanek, 1985; Hermanek, 1986) . The diffuse gastric carcinoma tends to spread more extensively in the gastric wall, often as the linitis plastica type of growth. The intestinal-type carcinoma, on the other hand, often grows as an exophytic tumour that may give rise to early symptoms of obstruction. Also, it is our experience that among gastric carcinoma patients with tumour in the vicinity of the resection border, there was an overweight of diffuse tumours (to be published).
We have recently presented evidence that the two types of gastric carcinoma are aetiologically different (Janssen et al., 1991 
